retatrutide ema approval Phase 3 results for have been released, and the data are generating a lot of discussion in obesity medicine. TRIUMPH-1 enrolled 2,339 adults with obesity or overweight and followed participants for Retatrutide Approval Status 2026: Approved

Diarrhea: GLP-1 agonists can slow gastric emptying, leading to gastrointestinal discomfort and diarrhea in some individuals

This is especially important considering a recent finding that colorectal cancer has now taken the lead as the top cause of cancer-related death among people under the age of 50 in the United States

Healing Timeline: What to Expect Understanding whats normal during recovery can help ease any anxiety about the healing process

There are no doctors, labs, dose adjustments, or safety monitoring, which matters for people who want guidance and accountability

Although this surgery is currently the accepted treatment, it requires a significant and growing share of medical resources, especially through Medicare

Stopping Does Not Mean Failure Weight regain after discontinuation does not necessarily mean the medication failed